IKIan Scott Kendall

Ian Scott Kendall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ian Scott Kendall has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Frank Casey

    School of Medicine, Dentistry and Biomedicine, Queen's University Belfast, University Road, Belfast, UK

    7 shared publications
  • Pascal McKeown

    School of Medicine, Dentistry and Biomedicine, Queen's University Belfast, University Road, Belfast, UK

    6 shared publications
  • Martin Dempster

    School of Psychology, Queen's University, University Road, Belfast, UK

    5 shared publications
  • Andrea Greco

    Arrhythmias, Inherited Cardiac Diseases and Sudden Death Unit, Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain

    4 shared publications
  • Terence Prendiville

    Paediatric Cardiology Department, Children’s Health Ireland at Crumlin, Dublin, Ireland

    4 shared publications
  • Andrew J Sands

    Paediatric Cardiology, Royal Belfast Hospital for Sick Children, Belfast, County Antrim, UK

    3 shared publications

Latest Publications

  • Open Access

    Incidence, Genetic Characteristics, and Outcomes of Paediatric Cardiomyopathy in a National Cohort (2003–2025)

    by Scott Kendall, Shannon Scott, Peter McClung, Joy McCance, Nawab Ali, Gillian Rea, William Wright, Jane Murray, Alison Muir, Martin Dempster, et al.

    Paediatric cardiomyopathy is a rare, serious inherited cardiac condition and a leading indication for paediatric heart transplantation. Population-based data describing paediatric cardiomyopathy within a single healthcare system complements multinational registry studies by providing important local epidemiological context. To describe the incidence, temporal trends, phenotypic characteristics, genetic findings, and clinical outcomes of paediatric cardiomyopathy in Northern Ireland over a 22-year period. A national retrospective cohort study of children diagnosed with cardiomyopathy in Northern Ireland between 2003 and 2025 was conducted. Population-based incidence rates were calculated for children aged 0–15 years affected by Dilated and Hypertrophic Cardiomyopathy using annual population denominators (2003–2023), with exact Poisson 95% confidence intervals. Temporal trends were assessed using quasi-Poisson and negative binomial regression models with population offsets. Clinical characteristics, genetics and outcomes (implantable cardioverter-defibrillator implantation, transplantation, and death) were analysed descriptively. Kaplan–Meier survival analysis and Cox regression were performed using a composite outcome of death or transplantation. Eighty-four children were diagnosed during the study period, corresponding to a mean annual incidence of 0.9 per 100,000 children. Annual incidence varied from 0.26 to 3.11 per 100,000. There was no statistically significant temporal increase in incidence ( p = 0.058), although higher incidence values were observed in more recent years. HCM ( n = 38, 45%) and DCM ( n = 24, 29%) were the most common subtypes. Overall, 61% of patients had a pathogenic or likely pathogenic genetic variant or phenocopy condition identified. There were seven deaths, six cardiac transplants, and eighteen implantable cardioverter-defibrillator insertions. Children diagnosed before one year of age accounted for 65% of deaths or transplants. Compared with HCM, DCM was associated with a significantly increased risk of death or transplantation (hazard ratio 6.25, 95% CI 1.30–33.33, p = 0.0094). Paediatric cardiomyopathy remains rare in Northern Ireland with a similar incidence to previous international reports but is associated with substantial morbidity and mortality, particularly among infants and those with DCM. Although higher annual estimates were observed in more recent years, no statistically significant temporal increase was identified. Ongoing population-based surveillance and integration with international registries are essential to improve understanding and outcomes in these rare conditions.


  • Open Access

    When Two Rare World Collide - A Case Report on the Co-occurrence of Gastroschisis and Hypoplastic Left Heart Syndrome

    by Obinna Akaleme, Ian Scott Kendall, Niamh Murphy, Kerri Munn-Bookless, Brian McCrossan, Andrew J. Sands

    Gastroschisis and Hypoplastic Left Heart Syndrome (HLHS) are rare congenital anomalies that are associated with infant morbidity and mortality. Gastroschisis, a defect in the abdominal wall, and HLHS, a severe congenital cardiac lesion, are not known to share any specific embryological or genetic aetiologies. Here, we report an infant with Gastroschisis with co-existing HLHS and present a brief literature review of factors that predispose to both conditions.

  • Open Access

    Physical activity and competitive sport safety for children affected by inherited cardiac conditions and selected acquired cardiomyopathies: emerging evidence and areas for further inquiry

    by Scott Kendall, Andrea Greco, Nicoletta Cantarutti, Andreia Constante, Daniel Diaz-Gil, Simon D’HUlst, Roger Esmel-Vilomara, José Luis López-Guillén, Katarzyna Luczak-Wozniak, Gian L. Ragazzoni, et al.

    Physicians tasked with caring for children with inherited cardiac conditions (ICCs) face complex decisions regarding safe participation in physical activity and competitive sport. Historically, concerns over sudden cardiac death (SCD) and disease progression led to widespread exercise restrictions. However, emerging evidence and evolving guidelines now support a more nuanced, risk-based approach. This narrative review explores current recommendations for exercise in children with major ICCs—including channelopathies, cardiomyopathies, and aortopathies. It highlights advances in risk stratification, the use of exercise testing, cardiac imaging, and genetic information to guide individualised recommendations. Shared decision-making (SDM) is emphasised as central to balancing arrhythmic and disease progression risk with the substantial physical, psychological, and social benefits of exercise. The review also discusses non-inherited conditions like anthracycline-induced cardiomyopathy and myocarditis. Despite progress, substantial variation exists in international guidelines, and there remains a paucity of paediatric-specific data. This poses a significant challenge and often necessitates utilising adult data when making decisions for children. Conclusion : Further research, including registries and multi-centre studies, is essential to improve evidence-based recommendations and empower clinicians, patients, and families in decision-making. A personalised approach—grounded in expertise, communication, and longitudinal follow-up—is critical to safely supporting children with ICCs in leading active, fulfilling lives. What is Known: • Inherited cardiac conditions (ICCs) are associated with ventricular arrhythmia, heart failure, and sudden cardiac death (SCD) prompting caution around sports and physical activity. • Myocarditis and anthracycline-induced cardiomyopathy are common aetiologies of cardiac dysfunction. What is New: • Observational studies in paediatric cohorts are reassuring for continued participation in sports following guideline-directed shared decision-making. • Cardiac rehabilitation improves left ventricular function in paediatric cancer survivors. Graphical Abstract

  • Open Access

    “What impact does having a diagnosis of an inherited cardiac condition have on children and young people’s physical activity and quality of life?” A scoping review

    by Scott Kendall, Veda Maha Kyla Murugaperumal, Andrea Greco, Terence Prendiville, Martin Dempster, Pascal McKeown, Frank Casey

    Inherited cardiac conditions (ICCs) are an umbrella group of genetic disorders affecting the heart. They are life-long conditions that are often diagnosed through family screening or after cardiac events. For many years, it has been customary practice to restrict physical activity (PA) in children to prevent ventricular arrhythmia or sudden cardiac death. This scoping review aims to identify and analyse the current literature on the impact that having a diagnosis of an ICC has on a young person’s PA and quality of life (QoL). This scoping review follows the methods of Arksey and O’Malley. Studies concerned with QoL and PA published between 1957 and 2025 were included. Literature searches were conducted across the following databases: Medline (Ovid), Scopus, Web of Science, Embase (Ovid) CINAHL, and PsycINFO. The data was extracted and charted focussing on aims, study populations, measures, and results. Data was then summarised with a descriptive summary as well as visual mapping and descriptive statistics. The review was conducted using the Preferred Reporting Items for Scoping Reviews guidelines. From a total of 1358 identified articles, 27 articles were included in the final review. There were twenty quantitative articles, three mixed method, and four qualitative studies included. Reduced QoL and mental health issues were common in this cohort. Children with ICCs had lower reported and measured PA in comparison to healthy peers. Lower PA was associated with reduced QOL amongst patients with ICCs. Themes identified in qualitative studies included activity restriction, fear of cardiac events, a need for improved communication by healthcare professionals, re-orientation, and coping. Conclusion : Children and young people with ICCs appear to have poorer QoL and engage in less PA than healthy peers. Empowering them to safely engage in PA should be a priority for healthcare providers. Consistent outcome measure across future studies would improve wider applicability of the findings. What is Known: • Children and young people with inherited cardiac conditions are subject to physical activity restrictions .• Being affected by an inherited cardiac condition is associated with poorer heatlth related quality of life . What is New: • Children and young people have lower reported and measured PA in comparison to healthy peers (in excess of that advised by restrictions) .• Lower Physical Activity is associted with reduced Quality of life amongst young people with ICCS .

  • Is it safe for my patient with congenital long QT syndrome to participate in competitive sports?

    by Ian Scott Kendall, Andrea Greco, Georgia Sarquella-Brugada, Martin Dempster, Pascal McKeown, Terence Prendiville, Frank Casey


  • Open Access

    Beta-blocker prescription adherence of children and young people with long QT syndrome: a retrospective cohort study

    by Ian Scott Andrew Kendall, Brandon Cooke, Adeline Jose, Solomon Nasir, Martin Dempster, Terence Prendiville, Pascal McKeown, Frank Casey

    Background: Beta blocker non-adherence is a key factor in precipitating cardiac events in patients affected by congenital long QT syndrome. Adherence has been examined in adults affected by congenital long QT syndrome but not in a large paediatric group. Method: Patients with congenital long QT syndrome types 1 and 2 were identified using a database curated by the Inherited Cardiac Conditions team in Northern Ireland. Medication adherence was reviewed by contacting the patient’s GP. A medication possession ratio was then calculated for the year. Adequate adherence was defined as a ratio of ≥0.8, and ideal adherence was defined as a ratio of ≥1.0. Risk factor analysis for poor adherence was performed using multivariable binary logistic regression. Results: 99 patients’ data was suitable for analysis, 71 had LQT1 (78%) and 28 had LQT2 (28%). The median age of the children involved was ten years old. Over 36,135 days the median medication possession ratio of this patient group was 0.92. 56 patients (57%) had at least adequate adherence, of these 44 patients (44%) had ideal adherence. In contrast 43 patients (43%) had less than adequate adherence and of these six patients (6%) were completely non-adherent. Increased deprivation was significantly associated with “less than” ideal adherence Odds Ratio (OR) 1.2 95% confidence intervals CI (1.1–1.4). Conclusion: Adherence in the paediatric cohort was mostly in the “adequate range.” Increased deprivation is a risk factor for “less than” ideal adherence. A small minority of patients can be identified as completely non-adherent by checking prescription records. Future studies should focus on elucidating barriers and enablers to ideal adherence in this population.


  • Tale of two blood gases

    by James Michael Griffith, Ian Scott Kendall, Sean T Kelleher, Alison Walker, Brian Grant

  • Open Access

    “What impact does having a diagnosis of an inherited cardiac condition have on children and young people’s physical activity and Quality of Life?”

    by Scott Kendall, Veda Maha Kyla Murugaperumal, Andrea Greco, Terence Prendiville, Martin Dempster, Pascal McKeown, Frank Casey

    Introduction The Inherited Cardiac Conditions are an umbrella group of genetic disorders affecting the heart. They are life-long conditions that are often diagnosed via family screening. For many years it has been customary practice to restrict physical activity in children to prevent Ventricular Arrhythmia or Sudden Cardiac Death. However, there has been a recent shift in advice, by some experts and centres especially in North America, to be less restrictive and allow unrestricted physical activity. Increased Physical activity and improved Quality of Life (QoL) have previously been linked in children affected by other diseases. Objective The proposed scoping review aims to identify and analyse the current literature on the impact that having a diagnosis of an ICC has on a young person’s physical activity and QoL. The findings will guide further study in this important area. Methods This scoping review will follow the Joanna Briggs Institute methodology.[SK1] Studies concerned with QoL and physical activity published between 1957 and 2025 will be included. The literature search will be conducted across the following databases: MEDLINE (Ovid), Scopus, Web of Science, Embase (Ovid), CINAHL and PsycINFO. Three reviewers will conduct title and abstract screening, with two reviewers conducting full-text screening; in the case that there are any conflicts these will be resolved by a senior independent reviewer. Ethics and Dissemination Ethical Approval is not required for this scoping review protocol. The protocol will be shared with researchers as an open access protocol. The findings of the review will be shared globally through an open-access peer-reviewed publication and by presenting at conferences. [SK1]No reference as it is an abstract

  • Open Access

    Epicardial Pacemaker Lead Related Cardiac Strangulation: The Importance of Early Recognition

    by Scott Kendall, Rihab Agouba, Jane Murray, Margaret Louise Morrison, Brian McCrossan, Brian Grant, Andrew Sands, Frank Casey, Lars Nolke

    Lead strangulation is a dangerous complication of epicardial pacemaker insertion. This complication has been increasingly highlighted lately. Our institution has recently identified four cases over the past five years. This study’s aim was to 1) identify risk factors for strangulation and 2) prospectively screen existing epicardial pacemaker patients for unrecognized strangulation or features that would prompt closer review. Patients known to the pacemaker clinic with epicardial pacemakers inserted from 2005 to 2023 were included. Electronic health records were used to locate all subjects and gather data. Risk factors were identified using Firth’s penalized method of logistic regression. Forty-five patients were included, of which four (8.8%) had evidence of strangulation. Posterior–anterior (PA) chest radiographs all demonstrated characteristic looping patterns of the pacing leads, with confirmation on CT angiography. All affected patients underwent revision surgery. Implantation at a weight of less than 6.5 kg was associated with a significantly increased incidence of strangulation (OR 25, P 0.044). Other factors including lead length, presence of structural cardiac disease, and dual-chamber insertion were not statistically significant. No patients who were prospectively screened were found to have strangulation. Children undergoing insertion of a pacemaker early in infancy are at particularly high risk of strangulation and should be closely monitored following surgery. Regular chest radiography (every three years) to screen for this complication is advised. Larger multi-center studies to pool data for this relatively rare complication may help identify other risk factors for strangulation.